Ono Pharmaceutical Co., Ltd. Logo

AbbVie and MBC BioLabs invite you to apply for the 2021 AbbVie Golden Ticket!

AbbVie and MBC BioLabs invite entrepreneurial scientists and founders to apply for a 2021 AbbVie Golden Ticket. The AbbVie Golden Ticket provides a year’s use of a lab bench and core facilities at MBC BioLabs’ San Francisco or San Carlos site, as well as opportunities to engage with AbbVie scientific and business leaders. It will be awarded to two early-stage companies developing novel, transformational therapies for autoimmune, oncology, neuroscience, eye care or aesthetics.

The winner of AbbVie’s Golden Ticket receives:

  • One year of free lab space and access to shared amenities and services provided by MBC BioLabs in San Francisco or San Carlos.
  • Access to the shared amenities and services provided at MBC BioLabs’ facility
  • Opportunities to engage with AbbVie scientific and business leaders.

To apply, please email your non-confidential company presentation to GoldenTicket@abbvie.com by October 19th, 2021.
In the application, please address:

  • What is the scientific insight and approach driving your company?
  • If successful, how would your therapeutic approach provide significant patient benefit beyond currently available treatment or other R&D stage programs?

Selected applicants will be invited to present their company to an expert AbbVie leadership panel at an event to be held virtually on December 2nd, 2021.

The deadline to apply for AbbVie’s Golden Ticket is October 19th, 2021.

We look forward to receiving your application. Contact us with any questions at GoldenTicket@abbvie.com or Flavia.Nachbar@mbcbiolabs.com

About MBC BioLabs

Learn More About MBC BioLabs

Rent a Bench. Change the World.

MBC BioLabs is dedicated to helping life-science startups succeed. By renting space as small as a single bench and providing these entrepreneurial scientists with access to millions of dollars of equipment, we allow companies to be fast, focused, and frugal. We now have three sites: one in the Dogpatch neighborhood in San Francisco and two campuses in San Carlos. Each site has a complete molecular biology core facility that allows companies to do experiments on day one, not year one. We have partnerships with leading pharmaceutical and life-science companies as well as a built-in venture capital firm, Mission BioCapital. These partnerships provide our entrepreneurs with valuable insights about where to focus their efforts and accelerates the innovation pipeline. Our labs have truly enabled awesome: since our opening in 2013 we have helped launch and grow 230 companies. These companies have brought 54 programs to the clinic, produced 13 approved diagnostics, and raised over $7 billion.

About AbbVie

Our ~48,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.

We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.

At AbbVie, we see a future full of possibility, where health is in reach and patient lives are improved. See our employees, our science and our hope for tomorrow:

Learn More About AbbVie